Vector Photonics Leads £1.5M Consortium - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Vector Photonics Leads £1.5M Consortium

    Article obtained from Photonics RSS Feed.

    Vector Photonics is leading the £1.5 million BLOODLINE project, an international consortium project developing PCSEL-based (photonic crystal surface-emitting laser) chips for 3D metal laser printing, funded by Innovate UK. According to a 2019 report from SmarTech Analysis, cited by Vector, the market is expected to reach $10 billion by 2025. The U.K.’s Compound Semiconductor Applications (CSA) Catapult will undertake chip reliability testing for the initiative, with two Japanese companies also participating — one a semiconductor manufacturer and the other an industrial equipment manufacturer — according to a press release from Vector.

    Jan, 27 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.